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Abstract
Background: The assessment of Quality of Life (QoL) is a Medical goal; it is used in clinical research, medical
practice, health-related economic studies and in planning health management measures and strategies. The
objective of this project is to develop an informational platform to achieve a patient self-assessment with
standardized QoL measuring instruments, through friendly software, easy for the user to adapt, which should aid
the study of QoL, by promoting the creation of databases and accelerating its statistical treatment and yet
generating subsequent useful results in graphical format for the physician analyzes in an appointment immediately
after the answers collection.
Methods: First, a software platform was designed and developed in an action-research process with patients,
physicians and nurses. The computerized patient self-assessment with standardized QoL measuring instruments
was compared with traditional one, to verify if its use did not influence the patient’s answers. For that, the
Wilcoxon and t-Student tests were applied. After, we adopted and adapted the mathematic Rash model to make
possible the use of QoL measure in the routine appointments.
Results: The results show that the computerized patient self-assessment does not influence the patient’s answers
and can be used as a suitable tool in the routine appointment, because indicates problems which are more
difficult to identify in a traditional appointment, improving thus the physician’s decisions.
Conclusions: The possibility of representing graphically useful results that physician needs to analyze in the
appointment, immediately after the answer collection, in an useful time, makes this QoL assessment platform a
diagnosis instrument ready to be used routinely in clinical practice.
Keywords: Heath and Neck Oncologic Patients, Health-Related Quality of Life, Knowledge Management Systems,
Decision Support Systems
Background
Scope
The concept of “Quality of Life - QoL” is used in differ-
ent contexts and situations, reaching practically all sec-
tors of society. The perception that an individual holds
about his place in life, which depends upon his culture
and values, defines this individual’s Quality of Life (QoL).
When applied in a health context this is known as:
Health-Related Quality of Life (HRQoL) [1]. Nowadays,
indicators of HRQoL are used in health management
strategies. Managers, economists, political analysts and
pharmaceutical companies use QoL measures from the
World Health Organization (WHO) in some of their
departments [2]. Today, HRQoL is a medical goal, being
used in epidemiological studies, clinical essays, medical
practice, health-related economic studies, and in plan-
ning and comparing measures and strategies [3].
Preliminary studies indicate that the implementation of
a patient HRQoL assessment in Portugal is challenged
and questioned for several factors involving health insti-
tutions, health professionals and patients [4]. The reasons
include: a lack of familiarity with relevant studies in this
area; the absence of sensitivity; lack of time; reluctance in
accepting that the patient’s perceptions regarding their
own outcomes are as important as the physicians [5]; dif-
ficulty in quantifying subjective parameters; difficulty in
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tence of friendly computer-based applications; inexis-
tence of health care service infrastructures that enable a
routine HRQoL assessment.
The purpose of this project is to allow the physician to
use patient’s QoL measurements as clinical decision sup-
port elements. A timely knowledge of the patient’sQ o L -
related elements constitutes another factor that may, in
certain circumstances, contribute to a better decision
making. On the other hand, a systematic patient QoL
data collection allows the standardization of this informa-
tion and to infer therapeutic strategies for a specific
patient. By other words, in the presence of several thera-
peutic strategies this can help the physician by giving
h i mc l u e sa b o u tt h ep a t i e n t ’s future QoL according to
applied medical acts.
In the this paper we intend to demonstrate the impor-
tance of HRQoL assessment in oncologic patients, and
the relevance of Knowledge Management Systems
(KMS) as decision making aids. We analyze this pro-
blem and show the results obtained with a platform
developed for the self-evaluation questionnaire that
measures patients QoL and collects clinical information
in order to infer about the patient future Qol through
crossing the QoL measure and the several treatments
used in the patients.
Evaluation of HRQoL in oncologic patients
Malignant tumors are the second leading cause of death
in Portugal. Their relevance as a morbidity and mortality
factor is growing and their social impact is being recog-
nized [1]. The global weight of oncologic disease is grow-
ing, given the economic and social costs involved in the
prevention, treatment and rehabilitation of it [6].
Research methods used in oncology enable us to analyze
the oncologic process in its physiopathologic and clinical
aspects, penetrating wide domains such as psychological,
social, economic and organizational domains [1]. Epide-
miology and statistics are significant areas of this study,
since oncologic care can only be programmed through
safe databases [7]. Assessing the implementation of these
diseases in our community helps to recognize the global
impact of tumors and to evaluate the effectiveness of the
adopted control measures [2].
The time where therapeutic decisions were not dis-
cussed with the patient and the family, and treatment
options were not even considered, has long since passed.
Oncologic patients were frequently not informed of their
diagnosis after their families were. This reality has chan-
ged and, today, patients participate, or should participate,
in the several stages of their treatment [1].
In fact, patients motivated to participate in their treat-
ment and rehabilitation plan often show a better QoL,
and should therefore be involved in the strategies
developed to fight their disease. Furthermore, evidence
shows that a global patient QoL optimization can
lead to a higher survival rate and to a higher quality of
life [1].
Promoting the integration of QoL assessment in clini-
cal practice can result in the optimization of infrastruc-
tures and methods capable of improving patients QoL
[8]. A validated, safe and scientifically-based measuring
instrument must be made available in a simple format,
understood both by the patient and the physician, for
being completed in less than 10 minutes [9].
Although being a subjective concept, HRQoL is quan-
tified objectively and does not merely represent the
inexistence of disease [10]. The multidimensional con-
ception of HRQoL comprises a wide range of physical,
psychological, functional, emotional and social variables,
which as a whole, define welfare [11]. These domains
vary individually according to religion and beliefs, cul-
ture, expectations, perceptions, education, knowledge,
etc. [11].
Table 1 represents schematically the mains HRQoL
dimensions and items, proposed by the WHO [12]:
KMS in routine HRQoL assessment
Preliminary studies on oncologic patients conclude that
the use of an adequate software for the HRQoL assess-
ment, data collection and processing, allows us to obtain
self-answered questionnaires from patients, an automatic
quotation of these questionnaires, the creation of a data-
base and the statistic analysis of the results, performing
a routine HRQoL clinical assessment [13].
Moreover, the graphical representation of results
enables a fast patient HRQoL assessment by the physi-
cian, and this evaluation becomes a diagnosis instru-
ment to be used in routine clinical practice [13].
HRQoL assessment is dynamic and requires periodic
reevaluations [14]. It should be done objectively and
quantitatively on a routine basis. Then, the selection of
a measuring instrument with good psychometric charac-
teristics, easy to administrate and to quantify, that
doesn’t increase the appointment time and with a multi-
dimensional character is most important. It must be
answered and quoted before appointments. The results
should remain confidential and anonymous, and when
graphically represented should allow an easy reading of
the patient’s self-perception. Thus, HRQoL assessment
becomes a diagnosis instrume n tt h a ti d e n t i f i e sp a t i e n t ’s
problems, highlights certain signs and symptoms that
could otherwise go unnoticed, improves the physician-
patient communication and assists therapeutic decisions;
in other words, it renders the appointments easier. By
analogy, the physician can evaluate the evolution of his
patient’s state comparing two or more assessments
obtained in different periods [15].
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new appointment protocol. The analysis and specifica-
tion of the information system requirements, as well as
the specification of necessary activities for the process,
define the knowledge management system which sup-
ports the clinical decision aid system, based on the
HRQoL assessment.
Methodology
A software platform to study the quality of life of oncol-
ogy patients was designed and developed in an action-
research process with patients, physicians and nurses.
In order to assess the impact created by the applica-
tion in the given answers we randomly selected patients
from the otorhinolaryngology service in Oporto’sI P O
(Portuguese Institute of Oncology). We selected fifteen
days from May, June and July of 2011, and all patients
attending consultations on those days were invited to
participate in this study. All of them accepted the invita-
tion and then we obtained a sample of 54 individuals
(Table 2). These patients answered the same question-
naire twice, one in paper form - the traditional model -
and the other on the computer using the software devel-
oped for that purpose, with 40 minutes temporal gap.
Half of the patients answered first on the paper form
and the other half answered first on the computer
platform, the minimum time between answers was 40
minutes. In both cases the answer time was measured
and the patient’s preference between the paper and the
computer was registered. Information regarding patient’s
affinity with computer use was also registered.
In order to understand if the computer-based environ-
ment influenced or not the answers we analyzed the
obtained values for each given answer, in both of the
assessment moments, using a collection of statistical
models and tests. Answers obtained in paper support and
through the computer-based platform were matched. To
understand if the computer-based platform did not influ-
ence the patients answers we hypothesized that distribu-
tions, for each variable in study, were identical. We first
tested the entire set of answers and then two subsets,
which divided patients that answered firstly on paper and
patients that answered firstly on the computer.
In the validation process two standardized question-
naires were used, both from EORTC (European Organi-
sation for Research and Treatment of Cancer): QLQ-
C30 and QLQ-H&N35. The first one is a global ques-
tionnaire developed for all types of oncologic patients. It
has thirty questions grouped in five domains (physical,
social, emotional, functional and cognitive). The second
is a specific questionnaire for Head and Neck oncology
patients, with thirty five questions.
The two statistical hypotheses for a bilateral test in
each situation were written.
Hypothesis H0 F(X0)=F ( X 1); HypothesisH1 :F ( X 0) <> F(X1).
We used the Wilcoxon test, the most appropriate
when the dependent variable is measured in an ordinal
scale [16]. In both of the questionnaires (QLQ-C30 and
QLQ-H&N35) adopted to evaluate the QoL the test
results did not allow to conclude if there were signifi-
cant differences between distributions, for the two sam-
ples and the three mentioned situations.
A high level of significance was always attained, inde-
pendently of the global or the partial analysis of the
sample, divided between those who firstly answered on
paper and those who firstly answered on the computer,
so the hypothesis of not existing a significant difference
Table 1 Dimensions and items for HRQoL assessment
QoL Domains
Physical Health Psychological Social Relationships Relationship with the Environment
Activities Self-Esteem Sexual Activity Economy
Pain Spirituality Social Support Information
Dyspnea Body Image Family Means of
Mobility Thoughts Personal transportation
Medication Negative Feelings relationships Security
Insomnia Positive Feelings Services
Free time
Table 2 Patients demographics
Gender Age
Male (37)
68,5%
Mean 57,0
95% Confidence Interval for Mean [52,9;61,1]
Std. Deviation 12,3
Minimum 22
Maximum 88
Female (17)
31,5%
Mean 63,7
95% Confidence Interval for Mean [56,6;71,0]
Std. Deviation 14,0
Minimum 40
Maximum 79
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the software use does not influence patient’s answers.
After the validation of the platform to obtain a patient
self-assessment with standardized QoL measuring
instruments, we adopted and adapted the mathematic
R a s hm o d e lt om a k ep o s s i b l et h eu s eo fQ o Lm e a s u r e
in the routine appointments.
The Rasch model estimates the question difficulty
level and the person ability level with an iterative pro-
cess. This process takes a lot of time and it is not com-
patible with a routine appointment. Thus, it was
necessary to understand how we could make the process
faster while maintaining accuracy in the values obtained
for the estimated parameters.
We analyze the running time by varying the number
of iterations and the sample size without losing accu-
racy. So, it was possible to determinate the sample size
and the number of iterations to calculate the parameters
that minimize the execution time.
In addition, we determine what were the calculations
that could be made in advance, that is, the calculations
that could be made before the appointment. Thus, the
time required for QoL assessment was reduced to five
minutes and you can use it in a routine assessment.
Results and discussion
Friendly software design
It cannot be denied that the health domain is extremely
sensitive, and every aspect that interferes with tradi-
tional processes is potentiated in terms of impact. Thus,
we started this project assessing the influence that a
technological environment would have in the patient’s
behavior.
Knowledge management systems can and should be
used in order to optimize certain procedures, but the
type of organization where they are introduced in must
be kept in mind. Dimensions and items for a model of
knowledge management were presented in Table 1.
The purpose of this project involves the development
o fa ni n f o r m a t i o n a lp l a t f o r mt h a tw o u l dn o ti n t e r f e r e
with patient’s answers when used, and which could be
applied by health professionals. This software should
run through a browser working in the health unit’s
intranet, or even in the internet.
The main requirement in the creation of this software
was to build an interface as close to a traditional paper
form as possible. Using key-words like usability, accessibil-
ity and confidentiality, the intention was to build a simple
interface with an intuitive use, where the correction to an
answer could be done in a clear, objective way, where the
patient could clearly understand the confidentiality of his
answers, and accessible to all types of patients. Blind, illit-
erate and physically challenged individuals are recurrent
amongst the frequent oncology service patients of the IPO
in Oporto. Sound or touch screens are presently the two
used interface solutions, but we are still investigating the
use of other communication devices.
Next, we present two figures. Figure 1 shows a view of
the QoL screen and Figure 2 shows a view of the
patient’s screen when he answers the questionnaire.
Figure 1 View of the QoL screen.
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The following graphics (Figure 3 and 4) show, for each
question, the percentage of equal and different answers
given by patients answering on the computer, compar-
ing with answers given on paper.
We thus concluded that the answers given by patients
on paper and on the computer-based platform are gen-
erally the same. Answers q1, q2, q22 of QLQ-C30 and
answer h41 of QLQ-H&N35 show the higher number of
different answers, a little over 40% in the case of h41
and fewer than 40% on the other cases.
It is worth noting that the specific questionnaire
(QLQ-H&N35) reveals a higher proportion of equal
answers. Ideally, the answers should always be the same,
but previous experiments (performed on paper) show
that answers given by patients in two separate moments
are sometimes different, and the percentage for this dif-
ference is close to the one we observed between the
answers on paper and the answers on the computer.
This confirms the results observed in the mentioned
test, leading us to conclude that the different results are
caused by other factors.
The Wilcoxon test results (Table 3 and Table 4) sug-
gest the not rejection of null hypothesis, in fact for all
answers the significance level is minor that 0,05. So we
cannot conclude that the answers are not similar
between paper support and computer support.
The rejection of null hypothesis do not guarantee that
answers are similar, so we analyze the correlation
between both answers, and we create a linear regression
line (y = mx + b) to analyze the coefficient of dependent
(m) variable and the independent term (b).
The linear regression analysis allowed conclude for all
questions that the coefficient of dependent variable
value was near from one (1) and the independent term
value was near from zero (0). The worst obtained value
was in question 16 where the values were 1,038 and
0,017 respectively. The correlation coefficient was 0,853.
Therefore we realized a t-Student test to verify if the
coefficient of dependent variable value could be zero in
the population. The test allowed to reject the null
hypothesis. In resume, can be concluded that the
answers are similar for both supports, i.e., the platform
does not influence the patient’s answers.
Additionally was asked to the patients data about their
impression with the platform in comparison with the
paper. So, we asked about their level like user in four
categories (none contact, a little contact, some contact
and substantial contact) and what they prefer: the paper
or the computer. The results are showed in Figure 5.
It is clear that except the patients that never use the
computer, the preference goes to the answer in the
computer platform. It should be emphasized the rela-
tionship between the level of computer use and prefer-
ence for answering in this way.
Data analysis
After the data registration stage, concerning the patient’s
QoL, it is important to forward this information in a
clear and objective way to the physician, to enable an
Figure 2 View of the patient when answering the questionnaire.
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clinical variables identification and development of the
output information obtained from physicians
contributions.
Measures verified in clinical analysis differentiate
patients from each other, but we understand that QoL
measuring should also be considered in patient
standardization.
We used the Rasch model [17] to analyze the patient
answers. An important feature of the Rasch model is the
sufficient raw score consistent estimation of item para-
meters without reference to the distribution of the latent
variable in the possible population. This feature allows
to analyze each answer from each patient individually
without concern with the other answers or the popula-
tion distribution.
Figure 6 shows a graphic with patient’sa n s w e r s :s i g -
naled in yellow are the answers below what is expected
for this type of patient, and signaled in blue are those
above the expected. In the right column are highlighted
the most critical answers in order to turn easier and
quick the physician understanding.
The advantage in using of th i sp l a t f o r mi sa l m o s tt h e
quick analysis by the physician about patient clinical
problems. In fact, the physician takes note about patient
problems before observing the patient. This information
facilitates and improves the conduction of the appoint-
ment. Without using the platform, it is not possible to
identify some signs and symptoms.
Clinical decision support system
Why do we consider this system as a clinical decision
support system?
In addition to the information about QoL the platform
can register the patient’s clinical information and socio-
demographic characteristics allowing to classify and
group patients according to these characteristics.
The collected data can help the physician in two
levels:
￿ Identify the problems that the patient has at the
moment;
￿ Assist the physician in decision-making by provid-
ing a forecast on future quality of life of the patient
according to the treatments prescribed.
It is important that the patient and the physician know
the effect that a treatment will have within 3, 4 or 5 years
Figure 3 QLQ-C30 Answers Comparison.
Gonçalves and Rocha Head & Neck Oncology 2012, 4:3
http://www.headandneckoncology.org/content/4/1/3
Page 6 of 9Figure 4 QLQ-HN35 Answers Comparison.
Table 3 Wilcoxon test results for QLQ-C30
q1 q2 q3 q4 q5 q6 q7 q8 q9 q10
Asymp. Sig. (2-tailed) 0,87 0,23 0,51 0,08 1,00 0,16 0,22 0,08 0,23 0,33
q11 q12 q13 q14 q15 q16 q17 q18 q19 q20
0,19 1,00 0,48 0,74 1,00 0,08 1,00 0,79 0,71 0,53
q21 q22 q23 q24 q25 q26 q27 q28 q29 q30
0,17 0,18 0,39 0,61 0,56 0,53 0,26 0,39 0,79 0,17
Table 4 Wilcoxon test results for QLQ-H&N 35
h31 h32 h33 h34 h35 h36 h37 h38 h39 h40
Asymp. Sig. (2-tailed) 0,56 0,79 0,66 0,94 1,00 0,44 0,92 0,06 0,32 0,76
h41 h42 h43 h44 h45 h46 h47 h48 h49 h50
0,44 0,54 0,58 0,08 0,91 0,48 1,00 0,30 0,51 0,25
h51 h52 h53 h54 h55 h56 h57 h58 h59 h60
0,25 0,89 0,55 0,59 0,32 0,47 0,68 1,00 0,36 1,00
h61 h62 h63 h64 h65
0,32 0,56 0,32 0,71 0,16
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Figure 6 Graphic with patient’s answers.
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tocol should include the patient’s QoL not necessarily
during the treatment but especially during the years fol-
lowing it. The objective measurement of patient’sQ o L
allows, in this context, to consider it as a clinical data
contribution to the characterization of the patient.
Conclusions
In this paper we defined the concept of QoL, in differ-
ent contexts and situations, which is reaching almost
every sector of society. The main focus, however, was
on the Health context.
Some studies have suggested that the implementation
of a patient HRQoL assessment in Portugal is chal-
lenged and questioned for several factors involving
health institutions, health professionals and patients [4].
The platform designed and developed in this project
gives the physician an opportunity to use patient’sQ o L
measurement in real time as a clinical decision support
element.
The knowledge about patient QoL constitutes another
factor that may, in certain circumstances, contribute to
a better decision. The systematic patient QoL data col-
lection allows the standardization of this information
and to infer therapeutic strategies for a specific patient.
Moreover, therapeutic alternatives can help the physi-
cian by giving him important data from which he can
infer the patient’s future QoL.
We proved the validity of the developed platform in
the acquisition of data required for the QoL assessment,
and in allowing a routine QoL assessment to become a
part of the appointment.
An evolution of the platform for collecting clinical
information, in order to typify patients and therapies
according to a specific patient’s QoL and a class of
patients, is under development. The need to develop
this platform underlines the importance of knowledge
management systems as decision making aids.
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